These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The Gamma-Aminobutyric Acid B Receptor in Depression and Reward. Jacobson LH; Vlachou S; Slattery DA; Li X; Cryan JF Biol Psychiatry; 2018 Jun; 83(11):963-976. PubMed ID: 29759132 [TBL] [Abstract][Full Text] [Related]
7. Ligand-guided homology modelling of the GABAB2 subunit of the GABAB receptor. Freyd T; Warszycki D; Mordalski S; Bojarski AJ; Sylte I; Gabrielsen M PLoS One; 2017; 12(3):e0173889. PubMed ID: 28323850 [TBL] [Abstract][Full Text] [Related]
8. Heterodimerization of the GABAB receptor-implications for GPCR signaling and drug discovery. Marshall FH; Foord SM Adv Pharmacol; 2010; 58():63-91. PubMed ID: 20655478 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of GABAB receptor subtypes assembled with auxiliary KCTD subunits. Rajalu M; Fritzius T; Adelfinger L; Jacquier V; Besseyrias V; Gassmann M; Bettler B Neuropharmacology; 2015 Jan; 88():145-54. PubMed ID: 25196734 [TBL] [Abstract][Full Text] [Related]
11. Differential modulation by the GABAB receptor allosteric potentiator 2,6-di-tert-butyl-4-(3-hydroxy-2,2-dimethylpropyl)-phenol (CGP7930) of synaptic transmission in the rat hippocampal CA1 area. Chen Y; Menendez-Roche N; Sher E J Pharmacol Exp Ther; 2006 Jun; 317(3):1170-7. PubMed ID: 16507713 [TBL] [Abstract][Full Text] [Related]
12. GABAB receptors as a therapeutic strategy in substance use disorders: focus on positive allosteric modulators. Filip M; Frankowska M; Sadakierska-Chudy A; Suder A; Szumiec L; Mierzejewski P; Bienkowski P; Przegaliński E; Cryan JF Neuropharmacology; 2015 Jan; 88():36-47. PubMed ID: 24971600 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of allosteric modulation at GABAB receptors by CGP7930 and GS39783: effects on affinities and efficacies of orthosteric ligands with distinct intrinsic properties. Urwyler S; Gjoni T; Koljatić J; Dupuis DS Neuropharmacology; 2005 Mar; 48(3):343-53. PubMed ID: 15721166 [TBL] [Abstract][Full Text] [Related]
14. The GABA Evenseth LSM; Gabrielsen M; Sylte I Molecules; 2020 Jul; 25(13):. PubMed ID: 32646032 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo pharmacological characterization of SSD114, a novel GABAB positive allosteric modulator. Porcu A; Lobina C; Giunta D; Solinas M; Mugnaini C; Castelli MP Eur J Pharmacol; 2016 Nov; 791():115-123. PubMed ID: 27578262 [TBL] [Abstract][Full Text] [Related]
16. New effects of GABAB receptor allosteric modulator rac-BHFF on ambient GABA, uptake/release, Em and synaptic vesicle acidification in nerve terminals. Pozdnyakova N; Dudarenko M; Borisova T Neuroscience; 2015 Sep; 304():60-70. PubMed ID: 26197223 [TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of metabotropic GABA Shaye H; Stauch B; Gati C; Cherezov V Sci Adv; 2021 May; 7(22):. PubMed ID: 34049877 [TBL] [Abstract][Full Text] [Related]